16 results · 44ms · Sources: EU EUDAMED, US FDA

Electromechanical System For Open Microsurgery

FDA classification
FDA Class 2 ·Electromechanical System For Open Microsurgery

Bag, Urine Collection, Leg, For External Use, Non-Sterile

FDA classification
FDA Class 1 ·Bag, Urine Collection, Leg, For External Use, Non-Sterile

Sensor, Pressure, Aneurysm, Implantable

FDA classification
FDA Class 2 ·Sensor, Pressure, Aneurysm, Implantable

Pipette, Sahli

FDA classification
FDA Class 1 ·Pipette, Sahli

Rongeur, Lachrymal Sac

FDA classification
FDA Class 1 ·Rongeur, Lachrymal Sac

Igg (Fd Fragment Specific), Antigen, Antiserum, Control

FDA classification
FDA Class 1 ·Igg (Fd Fragment Specific), Antigen, Antiserum, Control

Detector, Ultraviolet

FDA classification
FDA Class 2 ·Detector, Ultraviolet

Sars-Cov-2 Serology Test

FDA classification
FDA Class 2 ·Sars-Cov-2 Serology Test

Suture, Nonabsorbable, Steel, Monofilament And Multifilament, Sterile, Exempt

FDA classification
FDA Class 2 ·Suture, Nonabsorbable, Steel, Monofilament And Multifilament, Sterile, Exempt

Non-Sars Coronavirus Multiplex Nucleic Acid Assay

FDA classification
FDA Class 2 ·Non-Sars Coronavirus Multiplex Nucleic Acid Assay

Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

FDA classification
FDA Class 2 ·Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

Ngs Whole Genome Sequencing For Sars-Cov-2 Genetic Analysis

FDA classification
FDA Not Classified ·Ngs Whole Genome Sequencing For Sars-Cov-2 Genetic Analysis

Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

FDA classification
FDA Class 2 ·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

FDA classification
FDA Class 2 ·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

FDA classification
FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

FDA classification
FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings